Clinical trial
A Multicenter, Prospective, Phase II Clinical Trial Investigating the Use of Compression Stockings to Prevent Peripheral Neuropathy Induced by Antibody-Drug Conjugates (ADCs) in Patients With Urothelial Carcinoma
NCT07164950 is registered in ClinicalTrials.gov with Sheng Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Phase II Clinical Trial Investigating the Use of Compression Stockings to Prevent Peripheral Neuropathy Induced by Antibody-Drug Conjugates (ADCs) in Patients With Urothelial Carcinoma
- Lead sponsor
- Sheng Zhang
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 30, 2025
- Completion date
- July 1, 2026
- Enrollment
- 58 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumors, antibody-drug conjugates, chemotherapy-induced peripheral neuropathy, urothelial carcinoma